1099 — Sinopharm Co Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareBalancedLarge CapContrarian

Annual cashflow statement for Sinopharm Co, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	HKAS	HKAS	HKAS	HKAS	HKAS
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	15,598	17,003	18,564	19,512	14,001
Depreciation
Amortisation
Non-Cash Items	4,335	4,558	4,708	2,596	16,541
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital	-12,375	-16,175	-6,473	-9,365	-23,730
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Accounts Payable
Change in Accrued Expenses
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities	11,155	9,308	20,964	17,173	11,546
Capital Expenditures	-2,087	-2,256	-2,418	-2,336	-1,968
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items	-115	989	-1,172	1,391	-1,783
Acquisition of Business
Sale of Business
Sale of Fixed Assets
Sale/Maturity of Investment
Change in Net Investments
Purchase of Investments
Sale of Intangible Assets
Other Investing Cash Flow
Cash from Investing Activities	-2,203	-1,267	-3,590	-945	-3,751
Financing Cash Flow Items	-6,146	-5,997	-6,274	-5,471	-4,635
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	2,026	-14,693	-5,693	-7,644	-17,285
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	10,986	-6,649	11,692	8,587	-9,495